Clinical trial
An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with ABR-215757 (paquinimod)
To study changes in disease related biomarkers in patients with progressive SSc during treatment with ABR-215757
| Category | Value |
|---|---|
| Study start date | 2011-09-26 |